Segment Information

9 Months Ended

Oct. 02, 2020

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATIONThe Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics, and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.

Segment results are shown below ($ in millions):

	Three-Month Period Ended				Nine-Month Period Ended
	October 2, 2020		September 27, 2019		October 2, 2020		September 27, 2019
Sales:
Life Sciences	$	2,922.5	$	1,695.6	$	7,215.3	$	5,035.1
Diagnostics	1,889.1		1,601.9		5,176.3		4,757.0
Environmental & Applied Solutions	1,071.6		1,080.5		3,132.1		3,250.6
Total	$	5,883.2	$	4,378.0	$	15,523.7	$	13,042.7
Operating profit:
Life Sciences	$	504.9	$	342.5	$	1,242.9	$	995.5
Diagnostics	408.0		266.0		952.4		782.0
Environmental & Applied Solutions	245.1		256.5		707.0		761.3
Other	(70.4)		(88.7)		(272.6)		(231.1)
Total	$	1,087.6	$	776.3	$	2,629.7	$	2,307.7

Segment identifiable assets are shown below ($ in millions):

	October 2, 2020		December 31, 2019
Life Sciences	$	47,084.5	$	22,381.3
Diagnostics	14,715.9		14,442.2
Environmental & Applied Solutions	4,915.4		4,881.8
Other	6,174.9		20,376.3
Total	$	72,890.7	$	62,081.6